Cargando…
The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
OBJECTIVE: The co-infection of HCV/CMV may accelerate the progression of liver diseases and worsen responsiveness to IFN treatment. The Direct-acting antiviral agents (DAAs), currently approved therapy for HCV, may cause a transient change in immune status, favoring the reactivation of other viruses...
Autores principales: | Dawood, Reham M, Gomaa, Ahmed A, El-Meguid, Mai Abd, Hassan, Essam A, Salum, Ghada M, Fares, Hany Mahmoud, El Awady, Mostafa K, Fares, Eman M, Esmat, Gamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375591/ https://www.ncbi.nlm.nih.gov/pubmed/35485698 http://dx.doi.org/10.31557/APJCP.2022.23.4.1365 |
Ejemplares similares
-
Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
por: Salum, Ghada M., et al.
Publicado: (2019) -
Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2
por: Dawood, Reham M., et al.
Publicado: (2021) -
The Impact of COVID-19 on Liver Injury
por: Dawood, Dr. Reham M., et al.
Publicado: (2022) -
Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study
por: Dawood, Reham M, et al.
Publicado: (2021) -
Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
por: Salum, Ghada M., et al.
Publicado: (2021)